Novartis
NVS
#56
Rank
$175.97 B
Marketcap
$83.02
Share price
1.01%
Change (1 day)
-3.55%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

P/S ratio for Novartis (NVS)

P/S ratio as of March 2023 (TTM): 3.39

According to Novartis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.38873. At the end of 2022 the company had a P/S ratio of 3.77.

P/S ratio history for Novartis from 2001 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20223.771.33%
20213.72-14.86%
20204.36-1.11%
20194.4115.06%
20183.84-2.47%
20173.9312.4%
20163.50-15.42%
20154.141.29%
20144.0823.46%
20133.3125.02%
20122.6513.79%
20112.33-10.9%
20102.61-5.84%
20092.774.1%
20082.66-15.1%
20073.14-15.14%
20063.70-2.15%
20053.78-13%
20044.34-4.67%
20034.5516.84%
20023.90-18.42%
20014.78

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.08 49.96%๐Ÿ‡บ๐Ÿ‡ธ USA
2.29-32.54%๐Ÿ‡บ๐Ÿ‡ธ USA
3.98 17.39%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51-26.03%๐Ÿ‡ซ๐Ÿ‡ท France
4.54 34.06%๐Ÿ‡บ๐Ÿ‡ธ USA
3.06-9.63%๐Ÿ‡บ๐Ÿ‡ธ USA
4.62 36.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.82-46.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.6411-81.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel